5 Stocks That Weather Most Volatile Market Conditions

When the stock market swings wildly between gains and losses, most investors panic. The endless headlines about tariffs, interest rate decisions, and policy shifts create an atmosphere of uncertainty that tempts many to abandon stocks entirely. However, taking a tactical approach during most volatile market periods can actually work in your favor. Rather than sitting on the sidelines, savvy investors can identify companies with the fundamentals and characteristics to thrive regardless of short-term chaos.

Why Market Turbulence Creates Opportunity

Most volatile stock market conditions often coincide with the best buying opportunities for disciplined investors. When prices decline due to fear rather than fundamental deterioration, valuations become more attractive. The key is identifying which stocks possess the structural advantages—strong cash flows, diversified revenue streams, or essential services—that allow them to maintain performance when the broader market stumbles.

The five stocks highlighted here share a common thread: they possess characteristics that help them navigate uncertainty more effectively than average companies. Some offer income through dividends, others provide pricing power or niche market positions, and several benefit from structural tailwinds that transcend economic cycles.

Berkshire Hathaway: Diversification Through Volatility

While many holdings have suffered during 2025’s market gyrations, Berkshire Hathaway (NYSE: BRK.A, BRK.B) showcased remarkable resilience. The conglomerate’s share price climbed significantly over the year, benefiting from its fortress of subsidiaries and equity positions.

What makes Berkshire particularly compelling during uncertain times is its architecture. With more than 60 operating subsidiaries and 40-plus major stock holdings, the company benefits from natural portfolio diversification that most investors cannot achieve on their own. Warren Buffett’s investment discipline—waiting patiently for mispriced assets—becomes an advantage when markets overshoot in both directions.

Perhaps most importantly, Berkshire has accumulated the largest cash reserve in company history. This war chest positions the firm to deploy capital opportunistically as valuations become even more compelling. When volatility spikes and other investors fear the worst, Buffett’s dry powder becomes a strategic weapon.

Dominion Energy: Steady Returns Through Uncertainty

Utility stocks have long served as portfolios’ stabilizers when turbulence reigns. These companies enjoy predictable cash flows, regulatory protection, and natural defensiveness against competitive pressures. Among the utility sector’s best options, Dominion Energy (NYSE: D) stands out with distinctive advantages.

Two factors particularly appeal to value-conscious investors during most volatile market episodes. First, Dominion benefits from its Virginia headquarters proximity to the world’s largest data center hub, with continued expansion underway. These facilities demand massive electricity volumes, creating a secular growth tailwind for Dominion’s infrastructure and services.

Second, Dominion’s capital structure generates impressive income. The company’s dividend yield currently reaches 5%, while management projects annual earnings-per-share growth between 5% and 7%. This combination—reliable income plus steady growth—has historically delivered double-digit total returns with volatility considerably below the broader market. That profile appeals strongly during periods of uncertainty.

Enterprise Products Partners: Energy Infrastructure Resilience

Enterprise Products Partners (NYSE: EPD) operates as a midstream energy leader, moving natural gas, oil, and related liquids through an extensive pipeline network. While no energy company completely escapes market swings, Enterprise’s business model provides exceptional resilience.

During the worst energy sector crises over the past two decades, Enterprise maintained solid cash generation on a per-unit basis. This track record suggests the company can weather severe disruptions without sacrificing distributions.

Looking forward, Enterprise benefits from a significant structural tailwind: artificial intelligence’s rapid expansion. Data centers powering AI applications require enormous electricity volumes, which increasingly comes from natural gas generation. As this trend continues, demand for the natural gas and natural gas liquids flowing through Enterprise’s pipelines should rise accordingly. This secular growth driver, combined with the company’s 6.84% forward distribution yield, positions Enterprise to deliver compelling total returns even amid stock market volatility.

Pfizer: Valuation Creates Opportunity

Pfizer (NYSE: PFE) represents a contrarian selection—a stock that has fallen substantially as market participants worried about declining COVID-19 revenues and an approaching patent expiration cliff. This pessimism, however, has created two meaningful positives.

First, Pfizer’s dividend yield has expanded to above 7.5%, making the stock attractive for income-focused investors during uncertain periods. Second, and perhaps more important, valuation has become dirt cheap. Shares trade at only 7.6 times forward earnings—a level that prices in limited growth despite genuine opportunities ahead.

The company’s actual prospects prove stronger than the current stock sentiment suggests. Pfizer’s newer products demonstrate accelerating sales trajectories. Nurtec ODT and Padcev exemplify this momentum. More encouragingly, the company’s development pipeline contains 115 programs in various clinical stages, with 32 in late-stage testing. That depth provides multiple catalysts for future growth.

Vertex Pharmaceuticals: Secular Growth Amid Volatility

Vertex Pharmaceuticals (NASDAQ: VRTX) gained more than 20% during 2025, and that momentum should continue for two compelling reasons. First, Vertex’s market position transcends economic cycles. The company markets the only drugs targeting cystic fibrosis’s underlying cause, a functional cure for rare blood disorders, and what many consider the most promising non-opioid pain medication to reach the market in over twenty years. This portfolio means demand remains robust regardless of economic conditions.

Second, Vertex’s growth trajectory is accelerating, not decelerating. Its newest cystic fibrosis treatment gained U.S. approval in late 2024, while the non-opioid pain medication received approval in early 2025. Both drugs should become blockbuster performers for the company. Additionally, Vertex maintains four late-stage pipeline candidates with substantial commercial potential.

The beauty of Vertex’s position is its independence from macroeconomic outcomes. Whether equity market volatility persists or fades, whether economic conditions strengthen or weaken, Vertex’s fundamental growth drivers remain intact. This quality differentiates it meaningfully from cyclical businesses vulnerable to recessions or market downturns.

Building a Volatility-Resistant Portfolio

These five holdings share characteristics that explain their appeal during most volatile market conditions. Berkshire offers institutional-grade diversification. Dominion and Enterprise provide predictable income. Pfizer and Vertex present compelling valuations and growth opportunities. Collectively, they represent a framework for portfolio construction that doesn’t require perfect market timing or predictions about when turbulence will subside.

Rather than fleeing stocks during periods of uncertainty, consider that volatility often creates the conditions necessary for attractive risk-adjusted returns. These five companies exemplify that principle: they’re built to deliver through multiple market cycles and economic conditions.